HORIZON-JU-IHI-2024-07-03-singe-stage: Clinical validation of biomarkers for diagnosis, monitoring disease progression and treatment respon...
The expected impacts of the project include the availability of clinically-validated biomarker-driven approaches for more effective diagnosis, treatment selection, and monitoring. It aims to reduce the diagnostic and therapeutic burden on patients, provide evidence-based health decisions, and enhance the competitiveness of European health industries.
Áreas
Próximamente
Presentación
Minimum 3 independent legal entities based in 3 different Member States or Associated States, of which at least 1 is from a Member State. EU member states (Austria, Belgium, Bulgaria, Croatia, Cyprus, Czechia, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Ireland, Italy, Latvia, Lithuania, Luxembourg, Malta, Netherlands, Poland, Portugal, Romania, Slovakia, Slovenia, Spain, Sweden), Associated third countries (Albania, Armenia, Bosnia and Herzegovina, Faroe Islands, Georgia, Iceland, Israel, Kosovo, Moldova, Montenegro, New Zealand, North Macedonia, Norway, Serbia, Tunisia, Türkiye, Ukraine, United Kingdom), Other third countries. A partner from an EU or associated country must coordinate the project. Partners from other third countries cannot act as coordinators.
Puedes aplicar a ella en el siguiente link.
Objetivo
The objective of the call is to progress biomarkers and technologies towards clinical validation, addressing unmet public health needs and improving patient outcomes. Projects focus on assembling partnerships, developing methodologies, progressing candidate biomarkers, ensuring effective data sharing, and engaging with regulators and relevant healthcare stakeholders.
Temáticas
- Temática principal: Healthcare system, Diagnostic technology, Personalised care solutions, Personalised treatment, Drug development... ver más.
Características del líder del consorcio
Ambito
Categorias
Características del Proyecto
Requisitos
Requisitos
Capítulos
Tecnología
Características de la financiación
%
Intensidad de la ayuda: Sólo fondo perdido + info
10.0M - 15.0M €
Min - Max. Fondo perdido
The funding rate for RIA projects is 100 % of the eligible costs for all types of organizations.
Condiciones
Información adicional de la convocatoria
E. Incentiv.
Respuesta
Competitiva
Minimis
Otras ventajas
Sello